JENNIFER SIMPSON: Open Payments
NPI 1396275871 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 19 payments from 10 companies in 2025. Trend: 2023 $92 · 2024 $58 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $283 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Lilly USA, LLC | 2 | $45 |
| Exact Sciences Corporation | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| ABBVIE INC. | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| ABIOMED | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: FREESTYLE LIBRE 3, FARXIGA, The Cologuard Plus Collection Kit, Kerendia, JARDIANCE, AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
